← FDA Drug Approvals (Drugs@FDA)

DOCETAXEL

NDA · New Drug Application · Sponsor: AVYXA HOLDINGS · Approved 2022-11-22

Drug application

FDA Application #
NDA215813
Application type
New Drug Application
Brand name
DOCETAXEL
Generic name
DOCETAXEL
Active ingredients
DOCETAXEL
Dosage form
INJECTABLE
Route
INJECTION
Marketing status
Prescription
Sponsor
AVYXA HOLDINGS
Manufacturer
Avyxa Pharma, LLC
First approval
2022-11-22

Source

Authoritative
Drugs@FDA application overview
Machine
JSON-LD · Markdown